Neuroprotective Effects of Aucubin against Cerebral Ischemia and Ischemia Injury through the Inhibition of the TLR4/NF-κB Inflammatory Signaling Pathway in Gerbils

Joon Ha Park,Tae-Kyeong Lee,Dae Won Kim,Ji Hyeon Ahn,Myoung Cheol Shin,Jun Hwi Cho,Moo-Ho Won,Il Jun Kang
DOI: https://doi.org/10.3390/ijms25063461
IF: 5.6
2024-03-20
International Journal of Molecular Sciences
Abstract:Aucubin, an iridoid glycoside, possesses beneficial bioactivities in many diseases, but little is known about its neuroprotective effects and mechanisms in brain ischemia and reperfusion (IR) injury. This study evaluated whether aucubin exhibited neuroprotective effects against IR injury in the hippocampal CA1 region through anti-inflammatory activity in gerbils. Aucubin (10 mg/kg) was administered intraperitoneally once a day for one week prior to IR. Neuroprotective effects of aucubin were assessed by neuronal nuclei (NeuN) immunofluorescence and Floro-Jade C (FJC) histofluorescence. Microgliosis and astrogliosis were evaluated using immunohistochemistry with anti-ionized calcium binding adapter protein 1 (Iba1) and glial fibrillary acidic protein (GFAP). Protein levels of proinflammatory cytokines interleukin1 beta (IL1β) and tumor necrosis factor alpha (TNFα) were assayed using enzyme-linked immunosorbent assay and Western blot. Changes in toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) signaling pathway were assessed by measuring levels of TLR4, inhibitor of NF-κB alpha (IκBα), and NF-κB p65 using Western blot. Aucubin treatment protected pyramidal neurons from IR injury. IR-induced microgliosis and astrogliosis were suppressed by aucubin treatment. IR-induced increases in IL1β and TNFα levels were significantly alleviated by the treatment. IR-induced upregulation of TLR4 and downregulation of IκBα were significantly prevented by aucubin treatment, and IR-induced nuclear translocation of NF-κB was reversed by aucubin treatment. Briefly, aucubin exhibited neuroprotective effects against brain IR injury, which might be related to the attenuation of neuroinflammation through inhibiting the TLR-4/NF-κB signaling pathway. These results suggest that aucubin pretreatment may be a potential approach for the protection of brain IR injury.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the neuroprotective effect of **aucubin** (an iridoid glycoside isolated from *Aucuba japonica* and *Veronica persica*) in brain ischemia - reperfusion (IR) injury and its underlying mechanisms. Specifically, the study aims to evaluate whether aucubin can reduce neuroinflammation caused by brain ischemia - reperfusion by inhibiting the TLR4/NF - κB inflammatory signaling pathway, thereby providing protection for neurons in the hippocampal CA1 region. ### Research Background Transient global cerebral ischemia or ischemia - reperfusion (IR) is a medical emergency, usually occurring in adverse events such as cardiac arrest, shock, and asphyxia. Such events can lead to irreversible and permanent damage to specific brain regions (such as the hippocampus), ultimately resulting in neurological dysfunction. The CA1 region of the hippocampus is one of the particularly vulnerable structures in brain ischemia - reperfusion injury, with obvious neuronal loss occurring a few days later. The pathological processes include glutamate - dependent excitotoxicity, excessive reactive oxygen species - induced oxidative stress, and reactive glial cell - mediated neuroinflammation. Therefore, alleviating these processes may be one of the key methods for preventing and treating brain ischemia - reperfusion injury. ### Research Objectives The main objectives of the study are: 1. **Evaluate the neuroprotective effect of aucubin**: Evaluate the protective effect of aucubin on neurons in the hippocampal CA1 region after brain ischemia - reperfusion injury by immunofluorescence staining (NeuN) and tissue fluorescence staining (Flora - Jade C). 2. **Evaluate the effect of aucubin on neuroinflammation**: Evaluate the inhibitory effect of aucubin on microglial cell and astrocyte responses (microgliosis and astrogliosis) by immunohistochemistry (Iba1 and GFAP). 3. **Evaluate the effect of aucubin on inflammatory cytokines**: Detect the changes in protein levels of IL - 1β and TNF - α by ELISA and Western blot. 4. **Evaluate the effect of aucubin on the TLR4/NF - κB signaling pathway**: Detect the changes in protein levels of TLR4, IκBα, and NF - κB p65 by Western blot to understand whether aucubin exerts its anti - inflammatory effect by inhibiting this signaling pathway. ### Main Findings 1. **Neuronal protection**: Aucubin significantly protected pyramidal neurons in the hippocampal CA1 region from ischemia - reperfusion injury. 2. **Inhibition of neuroinflammation**: Aucubin significantly inhibited microgliosis and astrogliosis caused by ischemia - reperfusion. 3. **Reduction of inflammatory cytokine levels**: Aucubin significantly reduced the levels of IL - 1β and TNF - α caused by ischemia - reperfusion. 4. **Inhibition of the TLR4/NF - κB signaling pathway**: Aucubin significantly prevented the up - regulation of TLR4 and the down - regulation of IκBα caused by ischemia - reperfusion, and reversed the nuclear translocation of NF - κB. ### Conclusion The research results show that aucubin reduces neuroinflammation caused by brain ischemia - reperfusion by inhibiting the TLR4/NF - κB inflammatory signaling pathway, thereby having a significant neuroprotective effect on brain ischemia - reperfusion injury. These findings suggest that aucubin may become a potential strategy for preventing and treating brain ischemia - reperfusion injury.